Evidence map›Paper›PMID 39275150›Full record

Trial reportNutrients2024

Comparative Analysis of Nutritional Advice and a Combined Approach for Addressing Impending Stunting in Infants: A Clinical Trial.

Conny Tanjung, Bahrul Fikri, Titis Prawitasari, Nasrum Massi, Andi Alfian Zainuddin, Aidah Juliaty, Dwi Sora Yullyana, Sarah Dwitya, Naoki Shimojo, Hiroshi Ohno and 1 more

Abstract readClinical TrialComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Conny TanjungPost Graduate School, Hasanuddin University, Makassar 90245, Indonesia.ORCID 0000-0003-0180-5129
Bahrul FikriDepartment of Pediatrics, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
Titis PrawitasariDepartment of Child Health, Dr. Cipto Mangunkusumo National Central Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.ORCID 0000-0001-6788-7679
Nasrum MassiDepartment of Microbiology, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
Andi Alfian ZainuddinPublic Health and Community Medicine Department, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
Aidah JuliatyDepartment of Pediatrics, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
Dwi Sora YullyanaInstitute of Research and Community, Microbiome Research Division, Hasanuddin University, Makassar 90245, Indonesia.
Sarah DwityaTelkom Indonesia Health Foundation, Bandung 40133, Indonesia.
Naoki ShimojoCenter for Preventive Medical Sciences, Chiba University, Chiba 263-8522, Japan.
Hiroshi OhnoLaboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama 230-0045, Japan.ORCID 0000-0001-8776-9661
Berthold KoletzkoDepartment of Pediatrics, Dr. von Hauner Children's Hospital, LMU-Ludwig Maximilians Universität Munich, 80337 Munich, Germany.ORCID 0000-0002-5345-7165

Funding

Danone Specialized Nutrition Indonesia N/A
6 · The paper itself

Abstract

Weight faltering (WF) has been associated with stunting and with long-term adverse consequences for health and development. Nutritional care for managing WF may consist of giving nutritional advice (NA) and/or provision of oral nutrition supplements (ONSs). In this study, we aimed to evaluate practical management options in the community for infants with WF aged 6-12 months. This nonrandomized clinical trial was conducted in the community of Makassar, South Sulawesi, from March 2022 to March 2023. A total of 1013 infants were enrolled for screening. Anthropometric measures were performed in 913 infants, of which 170 showed WF below the 15th percentile of the WHO weight increment table without stunting. Infants with a weight increment below P5th were assigned to receive NA plus ONS, while infants between P5th and below P15th were assigned to receive only NA. At the second and third months, ONSs were administered to WF infants who were below P15th. One month after the intervention, 87/105 infants in the NA-plus-ONS group (82.8%) and 52/65 infants in the NA-only group (80%) were no longer WF. After 3 months, infants in the NA-plus-ONS group achieved greater weight gain than infants in the NA group (264.1 g vs. 137.4 g,

Indexed as

Dietary SupplementsGrowth DisordersInfant Nutritional Physiological PhenomenaFemaleHumansIndonesiaInfantMaleNutritional StatusWeight Gainnutritional adviceoral nutritional supplementsweight falteringweight increment

Identifiers

PMID39275150
PMCPMC11397034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.